Cencora Total Liabilities 2010-2025 | COR
Cencora total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Cencora total liabilities for the quarter ending March 31, 2025 were $70.014B, a 11.77% increase year-over-year.
- Cencora total liabilities for 2024 were $66.315B, a 7.15% increase from 2023.
- Cencora total liabilities for 2023 were $61.892B, a 9.56% increase from 2022.
- Cencora total liabilities for 2022 were $56.489B, a 0.47% decline from 2021.
| Cencora Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $66,315 |
| 2023 | $61,892 |
| 2022 | $56,489 |
| 2021 | $56,753 |
| 2020 | $45,114 |
| 2019 | $36,179 |
| 2018 | $34,620 |
| 2017 | $33,252 |
| 2016 | $31,508 |
| 2015 | $27,347 |
| 2014 | $19,575 |
| 2013 | $16,599 |
| 2012 | $12,987 |
| 2011 | $12,116 |
| 2010 | $11,481 |
| 2009 | $10,856 |
| Cencora Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $70,014 |
| 2024-12-31 | $68,692 |
| 2024-09-30 | $66,315 |
| 2024-06-30 | $65,712 |
| 2024-03-31 | $62,641 |
| 2023-12-31 | $63,629 |
| 2023-09-30 | $61,892 |
| 2023-06-30 | $60,255 |
| 2023-03-31 | $58,255 |
| 2022-12-31 | $57,833 |
| 2022-09-30 | $56,489 |
| 2022-06-30 | $56,656 |
| 2022-03-31 | $56,402 |
| 2021-12-31 | $56,976 |
| 2021-09-30 | $56,753 |
| 2021-06-30 | $55,523 |
| 2021-03-31 | $47,106 |
| 2020-12-31 | $46,358 |
| 2020-09-30 | $45,114 |
| 2020-06-30 | $36,822 |
| 2020-03-31 | $38,337 |
| 2019-12-31 | $36,948 |
| 2019-09-30 | $36,179 |
| 2019-06-30 | $35,371 |
| 2019-03-31 | $35,772 |
| 2018-12-31 | $36,103 |
| 2018-09-30 | $34,620 |
| 2018-06-30 | $35,034 |
| 2018-03-31 | $35,032 |
| 2017-12-31 | $33,487 |
| 2017-09-30 | $33,252 |
| 2017-06-30 | $32,101 |
| 2017-03-31 | $31,868 |
| 2016-12-31 | $31,803 |
| 2016-09-30 | $31,508 |
| 2016-06-30 | $30,035 |
| 2016-03-31 | $30,304 |
| 2015-12-31 | $29,456 |
| 2015-09-30 | $27,347 |
| 2015-06-30 | $25,758 |
| 2015-03-31 | $25,089 |
| 2014-12-31 | $23,137 |
| 2014-09-30 | $19,575 |
| 2014-06-30 | $18,644 |
| 2014-03-31 | $18,216 |
| 2013-12-31 | $17,548 |
| 2013-09-30 | $16,599 |
| 2013-06-30 | $14,161 |
| 2013-03-31 | $13,765 |
| 2012-12-31 | $13,158 |
| 2012-09-30 | $12,987 |
| 2012-06-30 | $12,818 |
| 2012-03-31 | $12,699 |
| 2011-12-31 | $13,074 |
| 2011-09-30 | $12,116 |
| 2011-06-30 | $11,653 |
| 2011-03-31 | $11,548 |
| 2010-12-31 | $11,170 |
| 2010-09-30 | $11,481 |
| 2010-06-30 | $11,073 |
| 2010-03-31 | $10,990 |
| 2009-12-31 | $10,815 |
| 2009-09-30 | $10,856 |
| 2009-06-30 | $9,951 |
| 2009-03-31 | $9,791 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $56.436B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $144.923B | 27.18 |
| CVS Health (CVS) | United States | $84.250B | 10.47 |
| Elevance Health (ELV) | United States | $79.134B | 10.21 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.062B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.762B | 17.65 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.704B | 0.00 |
| Solventum (SOLV) | United States | $13.538B | 14.33 |
| CochLear (CHEOY) | Australia | $12.960B | 0.00 |
| ICON (ICLR) | Ireland | $12.180B | 11.32 |
| Revvity (RVTY) | United States | $11.893B | 20.47 |
| Viatris (VTRS) | United States | $10.962B | 3.77 |
| Avantor (AVTR) | United States | $9.465B | 13.75 |
| Medpace Holdings (MEDP) | United States | $9.371B | 24.89 |
| HealthEquity (HQY) | United States | $8.758B | 38.36 |
| Sonic Healthcare (SKHHY) | Australia | $8.535B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.735B | 15.16 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.798B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.867B | 28.67 |
| BrightSpring Health Services (BTSG) | United States | $3.868B | 35.48 |
| Sotera Health (SHC) | United States | $3.304B | 18.77 |
| Surgery Partners (SGRY) | United States | $2.822B | 36.70 |
| Alignment Healthcare (ALHC) | United States | $2.693B | 0.00 |
| Concentras Parent (CON) | United States | $2.647B | 15.30 |
| Organon (OGN) | United States | $2.639B | 2.80 |
| GeneDx Holdings (WGS) | United States | $2.562B | 98.67 |
| PACS (PACS) | United States | $1.987B | 0.00 |
| Ardent Health (ARDT) | United States | $1.920B | 8.18 |
| Progyny (PGNY) | United States | $1.821B | 40.08 |
| GoodRx Holdings (GDRX) | United States | $1.805B | 36.11 |
| Premier (PINC) | United States | $1.789B | 13.58 |
| Teladoc Health (TDOC) | United States | $1.465B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.283B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.184B | 9.01 |
| CareDx (CDNA) | United States | $1.085B | 16.95 |
| Agilon Health (AGL) | United States | $0.989B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.843B | 7.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Nutex Health (NUTX) | United States | $0.679B | 10.28 |
| Embecta (EMBC) | United States | $0.599B | 4.04 |
| LifeMD (LFMD) | United States | $0.588B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.560B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.470B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
| Omada Health (OMDA) | $0.466B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.463B | 0.00 |
| Enhabit (EHAB) | United States | $0.390B | 32.12 |
| So-Young (SY) | China | $0.338B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.326B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.316B | 0.00 |
| Beauty Health (SKIN) | United States | $0.266B | 0.00 |
| Oncology Institute (TOI) | United States | $0.218B | 0.00 |
| DocGo (DCGO) | United States | $0.160B | 26.17 |
| Pheton Holdings (PTHL) | China | $0.121B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.092B | 0.00 |
| KindlyMD (NAKA) | United States | $0.079B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.027B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |